Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Extracellular Vesicles Released by Leishmania (Leishmania) amazonensis Promote Disease Progression and Induce the Production of Different Cytokines in Macrophages and B-1 Cells.

Barbosa FMC, Dupin TV, Toledo MDS, Reis NFDC, Ribeiro K, Cronemberger-Andrade A, Rugani JN, De Lorenzo BHP, Novaes E Brito RR, Soares RP, Torrecilhas AC, Xander P.

Front Microbiol. 2018 Dec 21;9:3056. doi: 10.3389/fmicb.2018.03056. eCollection 2018.

2.

Extracellular vesicles from Leishmania-infected macrophages confer an anti-infection cytokine-production profile to naïve macrophages.

Cronemberger-Andrade A, Aragão-França L, de Araujo CF, Rocha VJ, Borges-Silva Mda C, Figueira CP, Oliveira PR, de Freitas LA, Veras PS, Pontes-de-Carvalho L.

PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3161. doi: 10.1371/journal.pntd.0003161. eCollection 2014 Sep. Erratum in: PLoS Negl Trop Dis. 2014 Nov;8(11):e3415. Figueiras, Cláudio P [corrected to Figueira, Cláudio P].

3.

In vivo and in vitro phagocytosis of Leishmania (Leishmania) amazonensis promastigotes by B-1 cells.

Geraldo MM, Costa CR, Barbosa FM, Vivanco BC, Gonzaga WF, Novaes E Brito RR, Popi AF, Lopes JD, Xander P.

Parasite Immunol. 2016 Jun;38(6):365-76. doi: 10.1111/pim.12324.

4.

Leishmania amazonensis promastigotes in 3D Collagen I culture: an in vitro physiological environment for the study of extracellular matrix and host cell interactions.

Petropolis DB, Rodrigues JC, Viana NB, Pontes B, Pereira CF, Silva-Filho FC.

PeerJ. 2014 Apr 3;2:e317. doi: 10.7717/peerj.317. eCollection 2014.

5.

In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.

Paladi Cde S, Pimentel IA, Katz S, Cunha RL, Judice WA, Caires AC, Barbiéri CL.

PLoS Negl Trop Dis. 2012;6(5):e1626. doi: 10.1371/journal.pntd.0001626. Epub 2012 May 15.

7.

Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection.

Roma EH, Macedo JP, Goes GR, Gonçalves JL, Castro Wd, Cisalpino D, Vieira LQ.

Parasit Vectors. 2016 Apr 7;9:193. doi: 10.1186/s13071-016-1472-y.

8.

Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages.

de Souza Carmo EV, Katz S, Barbiéri CL.

PLoS One. 2010 Nov 3;5(11):e13815. doi: 10.1371/journal.pone.0013815.

9.

Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania.

Gomes IN, Calabrich AF, Tavares Rda S, Wietzerbin J, de Freitas LA, Veras PS.

Microbes Infect. 2003 Apr;5(4):251-60.

PMID:
12706438
12.

Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.

Wanasen N, Xin L, Soong L.

Int J Parasitol. 2008 Mar;38(3-4):417-29. Epub 2007 Sep 20.

13.

High dilutions of antimony modulate cytokines production and macrophage - Leishmania (L.) amazonensis interaction in vitro.

de Santana FR, Dalboni LC, Nascimento KF, Konno FT, Alvares-Saraiva AM, Correia MS, Bomfim MD, Casarin RC, Perez EC, Lallo MA, Peres GB, Laurenti MD, Benites NR, Buchi DF, Bonamin LV.

Cytokine. 2017 Apr;92:33-47. doi: 10.1016/j.cyto.2017.01.004. Epub 2017 Jan 13.

14.

Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.

Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.

Immunol Lett. 2006 May 15;105(1):38-47. Epub 2006 Jan 13.

PMID:
16466810
15.

Distinct Macrophage Fates after in vitro Infection with Different Species of Leishmania: Induction of Apoptosis by Leishmania (Leishmania) amazonensis, but Not by Leishmania (Viannia) guyanensis.

DaMata JP, Mendes BP, Maciel-Lima K, Menezes CA, Dutra WO, Sousa LP, Horta MF.

PLoS One. 2015 Oct 29;10(10):e0141196. doi: 10.1371/journal.pone.0141196. eCollection 2015.

16.

Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity.

França-Costa J, Wanderley JL, Deolindo P, Zarattini JB, Costa J, Soong L, Barcinski MA, Barral A, Borges VM.

PLoS One. 2012;7(5):e36595. doi: 10.1371/journal.pone.0036595. Epub 2012 May 4.

17.

Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa.

Giarola NL, Silveira TS, Inacio JD, Vieira LP, Almeida-Amaral EE, Meyer-Fernandes JR.

Exp Parasitol. 2014 Nov;146:25-33. doi: 10.1016/j.exppara.2014.08.013. Epub 2014 Aug 28.

PMID:
25176449
18.

IL-18 contributes to susceptibility to Leishmania amazonensis infection by macrophage-independent mechanisms.

Sousa LM, Carneiro MB, Dos Santos LM, Natale CC, Resende ME, Mosser DM, Vieira LQ.

Cytokine. 2015 Aug;74(2):327-30. doi: 10.1016/j.cyto.2015.01.021. Epub 2015 May 23.

19.

Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by Leishmania amazonensis.

Pereira JC, Ramos TD, Silva JD, de Mello MF, Pratti JES, da Fonseca-Martins AM, Firmino-Cruz L, Kitoko JZ, Chaves SP, Gomes DCO, Diaz BL, Rocco PRM, de Matos Guedes HL.

Front Immunol. 2017 Aug 10;8:893. doi: 10.3389/fimmu.2017.00893. eCollection 2017.

20.

Soluble factors from Leishmania major-specific CD4+T cells and B cells limit L. amazonensis amastigote survival within infected macrophages.

Mukbel R, Petersen CA, Jones DE.

Microbes Infect. 2006 Aug;8(9-10):2547-55. Epub 2006 Aug 1.

PMID:
16934514

Supplemental Content

Support Center